Publications

  • Ibáñez L. Agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2008;148:319-320.
  • Ibáñez L. Use of granulocyte colony-stimulating fractor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis. Pharmacoepidemiol Drug Safety 2008;17:224-228.  Link
  • Kaufman DW. Relative incidence of agranulocytosis and aplastic anemia. Am J Hematol 2006;81:65-67.  Link
  • Ibáñez I. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 2005;60:821-829.  Link
  • Ibáñez L. Population-based drug-induced agranulocytosis. Arch Intern Med 2005;165:869-874.  Link
  • Théophile H. Incidence of agranulocytosis in Southwest France. Eur J Epidemiol 2004;19:563-565.  Link
  • Grupo para el estudio de la agranulocitosis y la aplasia medular de Barcelona (GEAAMB). Utilización de factores de crecimiento de granulocitos en 145 episdios de agranulocitosis. Haematologica 2002;87:128.
  • Ibáñez L. Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug. Eur J Clin Pharmacol 2000;55:761-764.  Link
  • Ibáñez L. Agranulocytosis associated with calcium dobesilate. Clinical course and risk estimation with the case-control and the case-population approaches. Eur J Clin Pharmacol 2000;56:763-767.  Link
  • Capellà D. European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study. Eur J Clin Pharmacol 1998;53:299-302.  Link
  • Laporte JR. Gastrointestinal bleeding is common. Br Med J 1995;311:391-392.
  • Ibáñez L. Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach. Eur Heart J 1991;12:639-641.
  • Ibáñez L. Agranulocitosis asociada al uso de antitiroideos. Rev Farmacol Clín Exp 1990;7:100.
  • Laporte JR. Agranulocytosis induced by cinepazide. Eur J Clin Pharmacol 1990;38:387-388.
  • Ibáñez L. Comment: agranulocytosis caused by diclofenac?. Drug Intell Clin Pharm 1990;24:786.
  • Juan J. Pathophysiology and clinical course of agranulocytosis associated with parenteral high doses of ß-lactam antibiotics. Eur J Clin Pharmacol 1989;36:174.
  • International Agranulocytosis and Aplastic Anemia Study. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. Arch Intern Med 1989;149:1036-1040.  Link
  • International Agranulocytosis and Aplastic Anaemia Study. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. Br Med J 1988;297:262-265.  Link
  • Participants of the IAAAS. Reply to Kramer, Lane and Hutchinson. The International Agranulocytosis and Aplastic Anemia Study. J Chron Dis 1987;40:1083-1085.
  • Laporte JR. Blood dyscrasias and the relative safety of non-narcotic analgesics. Lancet 1987;329:809.
  • Laporte JR. Agranulocitosis y anemia aplásica inducidas por fármacos. Med Clín (Barc) 1987;88:555-558.
  • The International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 1986;256:1749-1757.  Link
  • Ibáñez L. L'agranulocitosi i l'anèmia aplàstica i llur relació amb l'ús de medicaments. L'Estudi Internacional sobre l'Agranulocitosi i l'Anèmia Aplàstica. Ann Med (Barc) 1983;69:209-220.
  • International Agranulocytosis and Aplastic Anemia Study. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. Eur J Clin Pharmacol 1983;24:833-836.
  • Ibáñez L. Agranulocitosis en el área de Barcelona. Resultados de dos años de seguimiento. Arch Farmacol Toxicol 1983;9:103-108.